Results of transvenous buttoned device occlusion of patent ductus arteriosus in adults

Echocardiography for Patent Ductus Arteriosus Including Closure in Adults

“…[51][52][53][54][55] There is no singular technique or device that can be used to close all PDA's successfully and therefore an interventionalist should have knowledge and familiarity of multiple devices and delivery methods. These include but are not limited to the following: Gianturco coils (both detachable and free), Amplatzer vascular plugs, Amplatzer muscular VSD device, Amplatzer PDA occluder, and the Amplatzer septal occluder.…”

Pulmonary perfusion scans following transcatheter patent ductus arteriosus closure using the Amplatzer devices

“…Since Porstmann et al reported on the first transcatheter closure of patent ductus arteriosus [14], a myriad of devices have been developed including: the Rashkind device, Buttoned device, butallooccluder device, and various coils [2,10,11,15,16]. The Rashkind device has fallen out of favor [13] due to the inherent complications associated with its use including residual shunting (varying between 3 and 38%) [17], device embolization, and impaired pulmonary blood flow, especially in smaller children [4,[18][19][20].…”

“…A variety of devices (Rashkind, Sideris buttoned device, Clamshell device, etc.) and coils (Gianturco coils, detachable coils, and flipper coils) have been used for closure of different angiographic types and sizes of PDA [6][7][8][9][10][11]. Among the potential complications associated with the use of these devices for closure of the PDA is obstruction to flow in the descending aorta (DAo) and obstruction to flow to the left pulmonary artery (LPA).…”

Transcatheter occlusion of ruptured sinus of valsalva aneurysm: Innovative use of available technology

“…Other devices, for example Duct Occlud [15,16], Amplatzer duct occluder [17][18][19], Gianturco-Grifka vascular occlusion device (GVOD) [20,21], and buttoned device [22,23], may also be potentially useful in occluding RSVA. The Duct Occlud and Amplatzer devices are available only at institutions participating in FDA-approved clinical trials and are not available for use at our institution.…”